Status:
RECRUITING
Deep Learning for Histopathological Classification and Prognostication of Gynaecologic Smooth Muscle Tumours
Lead Sponsor:
Institut Bergonié
Conditions:
Stump
Eligibility:
FEMALE
Brief Summary
Smooth muscle tumors of the uterus that do not fit the diagnostic criteria of benignity (such as leiomyomas) or malignancy (such as leiomyosarcomas) are called STUMP (smooth muscle tumor of uncertain ...
Eligibility Criteria
Inclusion
- Patients with a diagnosis of uterine smooth muscle tumors (leiomyomas, smooth muscle tumors of uncertain malignancy and leiomyosarcomas), registered in the RRePS database and/or treated at Institut Bergonié or one of the participating centers.
- Histopathological material available (kerosene blocks and/or slides).
Exclusion
- na
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
392 Patients enrolled
Trial Details
Trial ID
NCT06540846
Start Date
December 1 2023
End Date
December 1 2024
Last Update
August 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Bergonie
Bordeaux, France